Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Notes Payables (2020 - 2021)

Evolus (EOLS) has disclosed Notes Payables for 2 consecutive years, with $20.0 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Notes Payables changed N/A year-over-year to $20.0 million, compared with a TTM value of $20.0 million through Sep 2021, changed N/A, and an annual FY2020 reading of $19.1 million, changed N/A over the prior year.
  • Notes Payables was $20.0 million for Q3 2021 at Evolus, up from $19.6 million in the prior quarter.
  • Across five years, Notes Payables topped out at $20.0 million in Q3 2021 and bottomed at $19.1 million in Q4 2020.